Global Peripheral Intervention Drug Eluting Devices Market Research Report 2023(Status and Outlook)

April 2023 | 125 pages | ID: G1033E9183E2EN
Bosson Research

Abstracts

Report Overview
Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.
Bosson Research’s latest report provides a deep insight into the global Peripheral Intervention Drug Eluting Devices market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peripheral Intervention Drug Eluting Devices Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peripheral Intervention Drug Eluting Devices market in any manner.
Global Peripheral Intervention Drug Eluting Devices Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. Bard, Inc.
Abbott
The Lubrizol Corporation
Terumo Corporation

Market Segmentation (by Type)
Drug-Eluting Balloons
Drug-Eluting Stents

Market Segmentation (by Application)
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Peripheral Intervention Drug Eluting Devices Market
Overview of the regional outlook of the Peripheral Intervention Drug Eluting Devices Market:

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peripheral Intervention Drug Eluting Devices Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Peripheral Intervention Drug Eluting Devices
1.2 Key Market Segments
  1.2.1 Peripheral Intervention Drug Eluting Devices Segment by Type
  1.2.2 Peripheral Intervention Drug Eluting Devices Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Peripheral Intervention Drug Eluting Devices Market Size (M USD) Estimates and Forecasts (2018-2029)
  2.1.2 Global Peripheral Intervention Drug Eluting Devices Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET COMPETITIVE LANDSCAPE

3.1 Global Peripheral Intervention Drug Eluting Devices Sales by Manufacturers (2018-2023)
3.2 Global Peripheral Intervention Drug Eluting Devices Revenue Market Share by Manufacturers (2018-2023)
3.3 Peripheral Intervention Drug Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Peripheral Intervention Drug Eluting Devices Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Peripheral Intervention Drug Eluting Devices Sales Sites, Area Served, Product Type
3.6 Peripheral Intervention Drug Eluting Devices Market Competitive Situation and Trends
  3.6.1 Peripheral Intervention Drug Eluting Devices Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Peripheral Intervention Drug Eluting Devices Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES INDUSTRY CHAIN ANALYSIS

4.1 Peripheral Intervention Drug Eluting Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Type (2018-2023)
6.3 Global Peripheral Intervention Drug Eluting Devices Market Size Market Share by Type (2018-2023)
6.4 Global Peripheral Intervention Drug Eluting Devices Price by Type (2018-2023)

7 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peripheral Intervention Drug Eluting Devices Market Sales by Application (2018-2023)
7.3 Global Peripheral Intervention Drug Eluting Devices Market Size (M USD) by Application (2018-2023)
7.4 Global Peripheral Intervention Drug Eluting Devices Sales Growth Rate by Application (2018-2023)

8 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET SEGMENTATION BY REGION

8.1 Global Peripheral Intervention Drug Eluting Devices Sales by Region
  8.1.1 Global Peripheral Intervention Drug Eluting Devices Sales by Region
  8.1.2 Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Region
8.2 North America
  8.2.1 North America Peripheral Intervention Drug Eluting Devices Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Peripheral Intervention Drug Eluting Devices Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Peripheral Intervention Drug Eluting Devices Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Peripheral Intervention Drug Eluting Devices Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Peripheral Intervention Drug Eluting Devices Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Medtronic plc
  9.1.1 Medtronic plc Peripheral Intervention Drug Eluting Devices Basic Information
  9.1.2 Medtronic plc Peripheral Intervention Drug Eluting Devices Product Overview
  9.1.3 Medtronic plc Peripheral Intervention Drug Eluting Devices Product Market Performance
  9.1.4 Medtronic plc Business Overview
  9.1.5 Medtronic plc Peripheral Intervention Drug Eluting Devices SWOT Analysis
  9.1.6 Medtronic plc Recent Developments
9.2 Boston Scientific Corporation
  9.2.1 Boston Scientific Corporation Peripheral Intervention Drug Eluting Devices Basic Information
  9.2.2 Boston Scientific Corporation Peripheral Intervention Drug Eluting Devices Product Overview
  9.2.3 Boston Scientific Corporation Peripheral Intervention Drug Eluting Devices Product Market Performance
  9.2.4 Boston Scientific Corporation Business Overview
  9.2.5 Boston Scientific Corporation Peripheral Intervention Drug Eluting Devices SWOT Analysis
  9.2.6 Boston Scientific Corporation Recent Developments
9.3 Abbott Laboratories
  9.3.1 Abbott Laboratories Peripheral Intervention Drug Eluting Devices Basic Information
  9.3.2 Abbott Laboratories Peripheral Intervention Drug Eluting Devices Product Overview
  9.3.3 Abbott Laboratories Peripheral Intervention Drug Eluting Devices Product Market Performance
  9.3.4 Abbott Laboratories Business Overview
  9.3.5 Abbott Laboratories Peripheral Intervention Drug Eluting Devices SWOT Analysis
  9.3.6 Abbott Laboratories Recent Developments
9.4 Cardinal Health
  9.4.1 Cardinal Health Peripheral Intervention Drug Eluting Devices Basic Information
  9.4.2 Cardinal Health Peripheral Intervention Drug Eluting Devices Product Overview
  9.4.3 Cardinal Health Peripheral Intervention Drug Eluting Devices Product Market Performance
  9.4.4 Cardinal Health Business Overview
  9.4.5 Cardinal Health Peripheral Intervention Drug Eluting Devices SWOT Analysis
  9.4.6 Cardinal Health Recent Developments
9.5 B. Braun Melsungen AG
  9.5.1 B. Braun Melsungen AG Peripheral Intervention Drug Eluting Devices Basic Information
  9.5.2 B. Braun Melsungen AG Peripheral Intervention Drug Eluting Devices Product Overview
  9.5.3 B. Braun Melsungen AG Peripheral Intervention Drug Eluting Devices Product Market Performance
  9.5.4 B. Braun Melsungen AG Business Overview
  9.5.5 B. Braun Melsungen AG Peripheral Intervention Drug Eluting Devices SWOT Analysis
  9.5.6 B. Braun Melsungen AG Recent Developments
9.6 Biosensors International Group Ltd.
  9.6.1 Biosensors International Group Ltd. Peripheral Intervention Drug Eluting Devices Basic Information
  9.6.2 Biosensors International Group Ltd. Peripheral Intervention Drug Eluting Devices Product Overview
  9.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug Eluting Devices Product Market Performance
  9.6.4 Biosensors International Group Ltd. Business Overview
  9.6.5 Biosensors International Group Ltd. Recent Developments
9.7 C.R. Bard, Inc.
  9.7.1 C.R. Bard, Inc. Peripheral Intervention Drug Eluting Devices Basic Information
  9.7.2 C.R. Bard, Inc. Peripheral Intervention Drug Eluting Devices Product Overview
  9.7.3 C.R. Bard, Inc. Peripheral Intervention Drug Eluting Devices Product Market Performance
  9.7.4 C.R. Bard, Inc. Business Overview
  9.7.5 C.R. Bard, Inc. Recent Developments
9.8 Abbott
  9.8.1 Abbott Peripheral Intervention Drug Eluting Devices Basic Information
  9.8.2 Abbott Peripheral Intervention Drug Eluting Devices Product Overview
  9.8.3 Abbott Peripheral Intervention Drug Eluting Devices Product Market Performance
  9.8.4 Abbott Business Overview
  9.8.5 Abbott Recent Developments
9.9 The Lubrizol Corporation
  9.9.1 The Lubrizol Corporation Peripheral Intervention Drug Eluting Devices Basic Information
  9.9.2 The Lubrizol Corporation Peripheral Intervention Drug Eluting Devices Product Overview
  9.9.3 The Lubrizol Corporation Peripheral Intervention Drug Eluting Devices Product Market Performance
  9.9.4 The Lubrizol Corporation Business Overview
  9.9.5 The Lubrizol Corporation Recent Developments
9.10 Terumo Corporation
  9.10.1 Terumo Corporation Peripheral Intervention Drug Eluting Devices Basic Information
  9.10.2 Terumo Corporation Peripheral Intervention Drug Eluting Devices Product Overview
  9.10.3 Terumo Corporation Peripheral Intervention Drug Eluting Devices Product Market Performance
  9.10.4 Terumo Corporation Business Overview
  9.10.5 Terumo Corporation Recent Developments

10 PERIPHERAL INTERVENTION DRUG ELUTING DEVICES MARKET FORECAST BY REGION

10.1 Global Peripheral Intervention Drug Eluting Devices Market Size Forecast
10.2 Global Peripheral Intervention Drug Eluting Devices Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country
  10.2.3 Asia Pacific Peripheral Intervention Drug Eluting Devices Market Size Forecast by Region
  10.2.4 South America Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Peripheral Intervention Drug Eluting Devices by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)

11.1 Global Peripheral Intervention Drug Eluting Devices Market Forecast by Type (2024-2029)
  11.1.1 Global Forecasted Sales of Peripheral Intervention Drug Eluting Devices by Type (2024-2029)
  11.1.2 Global Peripheral Intervention Drug Eluting Devices Market Size Forecast by Type (2024-2029)
  11.1.3 Global Forecasted Price of Peripheral Intervention Drug Eluting Devices by Type (2024-2029)
11.2 Global Peripheral Intervention Drug Eluting Devices Market Forecast by Application (2024-2029)
  11.2.1 Global Peripheral Intervention Drug Eluting Devices Sales (K Units) Forecast by Application
  11.2.2 Global Peripheral Intervention Drug Eluting Devices Market Size (M USD) Forecast by Application (2024-2029)

12 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Peripheral Intervention Drug Eluting Devices Market Size Comparison by Region (M USD)
Table 5. Global Peripheral Intervention Drug Eluting Devices Sales (K Units) by Manufacturers (2018-2023)
Table 6. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Peripheral Intervention Drug Eluting Devices Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global Peripheral Intervention Drug Eluting Devices Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Intervention Drug Eluting Devices as of 2022)
Table 10. Global Market Peripheral Intervention Drug Eluting Devices Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Peripheral Intervention Drug Eluting Devices Sales Sites and Area Served
Table 12. Manufacturers Peripheral Intervention Drug Eluting Devices Product Type
Table 13. Global Peripheral Intervention Drug Eluting Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Peripheral Intervention Drug Eluting Devices
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peripheral Intervention Drug Eluting Devices Market Challenges
Table 22. Market Restraints
Table 23. Global Peripheral Intervention Drug Eluting Devices Sales by Type (K Units)
Table 24. Global Peripheral Intervention Drug Eluting Devices Market Size by Type (M USD)
Table 25. Global Peripheral Intervention Drug Eluting Devices Sales (K Units) by Type (2018-2023)
Table 26. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Type (2018-2023)
Table 27. Global Peripheral Intervention Drug Eluting Devices Market Size (M USD) by Type (2018-2023)
Table 28. Global Peripheral Intervention Drug Eluting Devices Market Size Share by Type (2018-2023)
Table 29. Global Peripheral Intervention Drug Eluting Devices Price (USD/Unit) by Type (2018-2023)
Table 30. Global Peripheral Intervention Drug Eluting Devices Sales (K Units) by Application
Table 31. Global Peripheral Intervention Drug Eluting Devices Market Size by Application
Table 32. Global Peripheral Intervention Drug Eluting Devices Sales by Application (2018-2023) & (K Units)
Table 33. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Application (2018-2023)
Table 34. Global Peripheral Intervention Drug Eluting Devices Sales by Application (2018-2023) & (M USD)
Table 35. Global Peripheral Intervention Drug Eluting Devices Market Share by Application (2018-2023)
Table 36. Global Peripheral Intervention Drug Eluting Devices Sales Growth Rate by Application (2018-2023)
Table 37. Global Peripheral Intervention Drug Eluting Devices Sales by Region (2018-2023) & (K Units)
Table 38. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Region (2018-2023)
Table 39. North America Peripheral Intervention Drug Eluting Devices Sales by Country (2018-2023) & (K Units)
Table 40. Europe Peripheral Intervention Drug Eluting Devices Sales by Country (2018-2023) & (K Units)
Table 41. Asia Pacific Peripheral Intervention Drug Eluting Devices Sales by Region (2018-2023) & (K Units)
Table 42. South America Peripheral Intervention Drug Eluting Devices Sales by Country (2018-2023) & (K Units)
Table 43. Middle East and Africa Peripheral Intervention Drug Eluting Devices Sales by Region (2018-2023) & (K Units)
Table 44. Medtronic plc Peripheral Intervention Drug Eluting Devices Basic Information
Table 45. Medtronic plc Peripheral Intervention Drug Eluting Devices Product Overview
Table 46. Medtronic plc Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 47. Medtronic plc Business Overview
Table 48. Medtronic plc Peripheral Intervention Drug Eluting Devices SWOT Analysis
Table 49. Medtronic plc Recent Developments
Table 50. Boston Scientific Corporation Peripheral Intervention Drug Eluting Devices Basic Information
Table 51. Boston Scientific Corporation Peripheral Intervention Drug Eluting Devices Product Overview
Table 52. Boston Scientific Corporation Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 53. Boston Scientific Corporation Business Overview
Table 54. Boston Scientific Corporation Peripheral Intervention Drug Eluting Devices SWOT Analysis
Table 55. Boston Scientific Corporation Recent Developments
Table 56. Abbott Laboratories Peripheral Intervention Drug Eluting Devices Basic Information
Table 57. Abbott Laboratories Peripheral Intervention Drug Eluting Devices Product Overview
Table 58. Abbott Laboratories Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 59. Abbott Laboratories Business Overview
Table 60. Abbott Laboratories Peripheral Intervention Drug Eluting Devices SWOT Analysis
Table 61. Abbott Laboratories Recent Developments
Table 62. Cardinal Health Peripheral Intervention Drug Eluting Devices Basic Information
Table 63. Cardinal Health Peripheral Intervention Drug Eluting Devices Product Overview
Table 64. Cardinal Health Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 65. Cardinal Health Business Overview
Table 66. Cardinal Health Peripheral Intervention Drug Eluting Devices SWOT Analysis
Table 67. Cardinal Health Recent Developments
Table 68. B. Braun Melsungen AG Peripheral Intervention Drug Eluting Devices Basic Information
Table 69. B. Braun Melsungen AG Peripheral Intervention Drug Eluting Devices Product Overview
Table 70. B. Braun Melsungen AG Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 71. B. Braun Melsungen AG Business Overview
Table 72. B. Braun Melsungen AG Peripheral Intervention Drug Eluting Devices SWOT Analysis
Table 73. B. Braun Melsungen AG Recent Developments
Table 74. Biosensors International Group Ltd. Peripheral Intervention Drug Eluting Devices Basic Information
Table 75. Biosensors International Group Ltd. Peripheral Intervention Drug Eluting Devices Product Overview
Table 76. Biosensors International Group Ltd. Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. Biosensors International Group Ltd. Business Overview
Table 78. Biosensors International Group Ltd. Recent Developments
Table 79. C.R. Bard, Inc. Peripheral Intervention Drug Eluting Devices Basic Information
Table 80. C.R. Bard, Inc. Peripheral Intervention Drug Eluting Devices Product Overview
Table 81. C.R. Bard, Inc. Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. C.R. Bard, Inc. Business Overview
Table 83. C.R. Bard, Inc. Recent Developments
Table 84. Abbott Peripheral Intervention Drug Eluting Devices Basic Information
Table 85. Abbott Peripheral Intervention Drug Eluting Devices Product Overview
Table 86. Abbott Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Abbott Business Overview
Table 88. Abbott Recent Developments
Table 89. The Lubrizol Corporation Peripheral Intervention Drug Eluting Devices Basic Information
Table 90. The Lubrizol Corporation Peripheral Intervention Drug Eluting Devices Product Overview
Table 91. The Lubrizol Corporation Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. The Lubrizol Corporation Business Overview
Table 93. The Lubrizol Corporation Recent Developments
Table 94. Terumo Corporation Peripheral Intervention Drug Eluting Devices Basic Information
Table 95. Terumo Corporation Peripheral Intervention Drug Eluting Devices Product Overview
Table 96. Terumo Corporation Peripheral Intervention Drug Eluting Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Terumo Corporation Business Overview
Table 98. Terumo Corporation Recent Developments
Table 99. Global Peripheral Intervention Drug Eluting Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 100. Global Peripheral Intervention Drug Eluting Devices Market Size Forecast by Region (2024-2029) & (M USD)
Table 101. North America Peripheral Intervention Drug Eluting Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 102. North America Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country (2024-2029) & (M USD)
Table 103. Europe Peripheral Intervention Drug Eluting Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 104. Europe Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country (2024-2029) & (M USD)
Table 105. Asia Pacific Peripheral Intervention Drug Eluting Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 106. Asia Pacific Peripheral Intervention Drug Eluting Devices Market Size Forecast by Region (2024-2029) & (M USD)
Table 107. South America Peripheral Intervention Drug Eluting Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 108. South America Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country (2024-2029) & (M USD)
Table 109. Middle East and Africa Peripheral Intervention Drug Eluting Devices Consumption Forecast by Country (2024-2029) & (Units)
Table 110. Middle East and Africa Peripheral Intervention Drug Eluting Devices Market Size Forecast by Country (2024-2029) & (M USD)
Table 111. Global Peripheral Intervention Drug Eluting Devices Sales Forecast by Type (2024-2029) & (K Units)
Table 112. Global Peripheral Intervention Drug Eluting Devices Market Size Forecast by Type (2024-2029) & (M USD)
Table 113. Global Peripheral Intervention Drug Eluting Devices Price Forecast by Type (2024-2029) & (USD/Unit)
Table 114. Global Peripheral Intervention Drug Eluting Devices Sales (K Units) Forecast by Application (2024-2029)
Table 115. Global Peripheral Intervention Drug Eluting Devices Market Size Forecast by Application (2024-2029) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Peripheral Intervention Drug Eluting Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peripheral Intervention Drug Eluting Devices Market Size (M USD), 2018-2029
Figure 5. Global Peripheral Intervention Drug Eluting Devices Market Size (M USD) (2018-2029)
Figure 6. Global Peripheral Intervention Drug Eluting Devices Sales (K Units) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peripheral Intervention Drug Eluting Devices Market Size by Country (M USD)
Figure 11. Peripheral Intervention Drug Eluting Devices Sales Share by Manufacturers in 2022
Figure 12. Global Peripheral Intervention Drug Eluting Devices Revenue Share by Manufacturers in 2022
Figure 13. Peripheral Intervention Drug Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market Peripheral Intervention Drug Eluting Devices Average Price (USD/Unit) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by Peripheral Intervention Drug Eluting Devices Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Peripheral Intervention Drug Eluting Devices Market Share by Type
Figure 18. Sales Market Share of Peripheral Intervention Drug Eluting Devices by Type (2018-2023)
Figure 19. Sales Market Share of Peripheral Intervention Drug Eluting Devices by Type in 2022
Figure 20. Market Size Share of Peripheral Intervention Drug Eluting Devices by Type (2018-2023)
Figure 21. Market Size Market Share of Peripheral Intervention Drug Eluting Devices by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Peripheral Intervention Drug Eluting Devices Market Share by Application
Figure 24. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Application (2018-2023)
Figure 25. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Application in 2022
Figure 26. Global Peripheral Intervention Drug Eluting Devices Market Share by Application (2018-2023)
Figure 27. Global Peripheral Intervention Drug Eluting Devices Market Share by Application in 2022
Figure 28. Global Peripheral Intervention Drug Eluting Devices Sales Growth Rate by Application (2018-2023)
Figure 29. Global Peripheral Intervention Drug Eluting Devices Sales Market Share by Region (2018-2023)
Figure 30. North America Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 31. North America Peripheral Intervention Drug Eluting Devices Sales Market Share by Country in 2022
Figure 32. U.S. Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 33. Canada Peripheral Intervention Drug Eluting Devices Sales (K Units) and Growth Rate (2018-2023)
Figure 34. Mexico Peripheral Intervention Drug Eluting Devices Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 36. Europe Peripheral Intervention Drug Eluting Devices Sales Market Share by Country in 2022
Figure 37. Germany Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 38. France Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 39. U.K. Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 40. Italy Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 41. Russia Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 42. Asia Pacific Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Peripheral Intervention Drug Eluting Devices Sales Market Share by Region in 2022
Figure 44. China Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 45. Japan Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 46. South Korea Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 47. India Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 48. Southeast Asia Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 49. South America Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (K Units)
Figure 50. South America Peripheral Intervention Drug Eluting Devices Sales Market Share by Country in 2022
Figure 51. Brazil Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 52. Argentina Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 53. Columbia Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 54. Middle East and Africa Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Peripheral Intervention Drug Eluting Devices Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 57. UAE Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 58. Egypt Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 59. Nigeria Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 60. South Africa Peripheral Intervention Drug Eluting Devices Sales and Growth Rate (2018-2023) & (K Units)
Figure 61. Global Peripheral Intervention Drug Eluting Devices Sales Forecast by Volume (2018-2029) & (K Units)
Figure 62. Global Peripheral Intervention Drug Eluting Devices Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global Peripheral Intervention Drug Eluting Devices Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global Peripheral Intervention Drug Eluting Devices Market Share Forecast by Type (2024-2029)
Figure 65. Global Peripheral Intervention Drug Eluting Devices Sales Forecast by Application (2024-2029)
Figure 66. Global Peripheral Intervention Drug Eluting Devices Market Share Forecast by Application (2024-2029)